PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,297,293 | -20.5% | 105,300 | -24.8% | 0.58% | -26.1% |
Q4 2022 | $5,407,331 | -27.4% | 140,050 | 0.0% | 0.79% | -51.4% |
Q3 2022 | $7,449,000 | -22.2% | 140,050 | -14.7% | 1.62% | -10.8% |
Q2 2022 | $9,576,000 | -24.7% | 164,250 | -1.5% | 1.82% | +7.3% |
Q1 2022 | $12,721,000 | +8.4% | 166,675 | -14.5% | 1.70% | +79.0% |
Q4 2021 | $11,733,000 | +19.7% | 195,000 | +11.4% | 0.95% | +39.3% |
Q3 2021 | $9,802,000 | -6.4% | 175,038 | +1.4% | 0.68% | +7.9% |
Q2 2021 | $10,470,000 | -18.3% | 172,538 | -5.6% | 0.63% | -29.2% |
Q1 2021 | $12,814,000 | +54.8% | 182,824 | +32.2% | 0.89% | +69.8% |
Q4 2020 | $8,277,000 | +141.9% | 138,324 | +143.0% | 0.52% | +125.9% |
Q3 2020 | $3,422,000 | +55.5% | 56,924 | +35.8% | 0.23% | 0.0% |
Q2 2020 | $2,200,000 | – | 41,924 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |